In this week's Research Ethics Roundup, we explore some of the ethical and practical questions posed by new innovations in the research enterprise, as well as some age old concerns, such as the recruitment of subjects for clinical trials. Read on:
FDA, Sponsors Look to Expand Patient Input to Clinical Trials: The involvement of patient groups in the design of clinical trials is becoming increasingly common. In this article for Applied Clinical Trials, Jill Wechsler reports on this shift, as well as the Food and Drug Administration's efforts to foster patient-focused drug development.
by Krystal Bradford, CIP, research compliance specialist at Cincinnati Children’s Hospital Medical Center
Since my last blog post, I have tried to pay closer attention to things discussed at the 2014 AER Conference that I have incorporated into my everyday work. Several items that stand out to me might be considered minor, but there is payoff in the end. One example is documentation.
If you have read any post-site visit letters from OHRP or FDA, there is almost always a reference to documentation that should have occurred but didn’t. Accurate research study [...] Read more
Perhaps you’ve already read – on your Facebook News Feed, no doubt – about Facebook’s recent mood experiment. Not to worry—this post has no hidden motive. We’re just pleased to be able to share recent headlines from around the research ethics world with you.
Everything We Know about Facebook’s Secret Mood Manipulation Experiment: Following the publication of a paper in the Proceedings of the National Academy of Sciences, [...] Read more
Did you catch the blood moon and the first lunar eclipse of the year? We hope so, but now it’s time to turn your gaze from the sky to the screen and catch up on what’s been going on in the field of research ethics!
The days are growing longer, spring is approaching, and before you can say Research Ethics Roundup, the crocuses will be emerging! Shake off the long winter and dig into some recent news stories on topics related to research ethics and oversight.